Factors that contribute to @entity190 in XXXX with @entity694 from a population-based study.

@entity1 @entity548 @entity190 @entity2817 @entity694 @entity221
BACKGROUND _ AIMS: Most studies of @entity2817 are small and performed at a single center. We investigated the epidemiology and management of @entity694 by using a national endoscopy database. METHODS: Colonoscopy reports (n = 229,727; generated from January 2000 to December 2002) from @entity1 with documented @entity2817 (n = 4159) were retrieved from the Clinical Outcomes Research Initiative. Predictors of occult or overt @entity190 and endoscopic treatment were identified by using multivariate logistic regression. RESULTS: Most @entity1 with documented @entity2817 were older than 60 years (73%) or had right-sided lesions (62%). There was evidence of @entity190 in 56% of @entity1 with @entity2817 . Predictors of @entity190 included inpatient status (odds ratio [OR], 8.74; 95% confidence interval [CI], 5.42-14.10), 2-10 @entity2817 (OR, 1.50; 95% CI, 1.29-1.75), more than 10 lesions (OR, 2.18; 95% CI, 1.69-2.80), black race (OR, 1.95; 95% CI, 1.46-2.62), severe @entity221 (OR, 1.97; 95% CI, 1.62-2.41), Hispanic ethnicity (OR, 1.71; 95% CI, 1.32-2.22), and age older than 80 years (OR, 1.32; 95% CI, 1.06-1.63). Endoscopic therapy was given to 28% of @entity1 with evidence of @entity190 and in 68% with active @entity548 . Endoscopic treatment increased among @entity1 in a university practice setting (vs community setting, OR, 2.53; 95% CI, 1.96-3.27) and decreased in Northwest geographic locations (vs Southwest, OR, 0.60; 95% CI, 0.43-0.84). CONCLUSIONS: Predictors of @entity190 in @entity1 with @entity694 include inpatient status, comorbidities, age, race/ethnicity, and lesion number. Endoscopic therapy for @entity2817 varied according to practice setting and region.
